PHOENIX, Aug. 03, 2017 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the Company”) today announced financial results for the three-month period ended June 30, 2017.
Highlights of and subsequent to the second quarter of 2017 include:
Total net revenue was $42.6 million, compared to $69.2 million for the second quarter of 2016;
